Kings Path Partners
OGN icon

Kings Path Partners’s Organon & Co OGN Stock Holding History

Kings Path Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$274 Buy
+20
New +$273 ﹤0.01% 362

Other funds holding OGN

Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 22.91% 1-Year Est. Return

Kings Path Partners's OGN Position: Q3 2026 in Review

Kings Path Partners opened a new position in Organon & Co (OGN) in Q3 2026: 20 shares worth $274. The stake represents ﹤0.01% of the portfolio and ranks #362 among its holdings.

473 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Kings Path Partners held 20 shares of Organon & Co worth $274 as of Q3 2026.
  • Organon & Co was a new Kings Path Partners position in Q3 2026.
  • Organon & Co made up ﹤0.01% of Kings Path Partners's portfolio in Q3 2026, its #362 holding.
  • 473 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.